GlomerulonephritisSymptoms, Doctors, Treatments, Advances & More
Glomerulonephritis Overview
Learn About Glomerulonephritis
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Northwell Health Physician Partners Kidney And Hypertension Specialists At Great Neck
"Kenar D. Jhaveri, MD, is Professor of Medicine and Associate Chief in the Division of Kidney Diseases and Hypertension at Northwell Health and Zucker School of Medicine at Hofstra/Northwell. He completed his residency training at Yale University New Haven Hospital in Internal Medicine and then a fellowship in Nephrology at New York Presbyterian Hospital-Weill Cornell campus. His clinical interests are in glomerular diseases and onconephrology( cancer and its effect on the kidney). He is the founding member of the American Society of Onconephrology. He is a columnist for the ASN Kidney News for the section called ""Detective Nephron."" His interest in nephrology education is vested in using creative ways of teaching nephrology to medical students, residents, and fellows. He has published on onconephrology, Glomerular diseases, AKI and also in using social media and other innovative tools (games, concept maps, role playing, creative writing) to make nephrology a fun and exciting field. His most recent projects are in learning about renal toxicities of targeted oncological agents, immunotherapies, and COVID related AKI and glomerular diseases.". Dr. Jhaveri is rated as an Elite provider by MediFind in the treatment of Glomerulonephritis. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Glomerulonephritis, Interstitial Nephritis, Low Sodium Level, Low Potassium Level, and Kidney Transplant. Dr. Jhaveri is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine/Nephrology.
BIDMC West Specialties Clinic-Nephrology
Martin Pollak is an Internal Medicine provider practicing medicine in Boston, Massachusetts. Dr. Pollak is rated as an Elite provider by MediFind in the treatment of Glomerulonephritis. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Focal Segmental Glomerulosclerosis, Glomerulonephritis, Nephrotic Syndrome, Chronic Kidney Disease, and Kidney Transplant. Dr. Pollak is board certified in American Board Of Internal Medicine.
Johns Hopkins Bayview Medical Center
Dr. Geetha is a Professor of Clinical Medicine in the Division of Nephrology, Johns Hopkins University School of Medicine. A graduate of Madras Medical College, India, she completed Internal Medicine training in U.K. She did her Internal Medicine Residency at York, PA and Nephrology fellowship at Johns Hopkins Bayview Medical Center. She has been on Hopkins faculty since 1998. She is the Associate Director of the Johns Hopkins Vasculitis Center and co-director of the Johns Hopkins Glomerular Disease Clinic. She is a member of Royal College of Physicians (U.K.) and Fellow of the American Society of Nephrology. She was inducted to the Miller Coulson Academy of Clinical Excellence. Dr. Geetha is rated as an Elite provider by MediFind in the treatment of Glomerulonephritis. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Glomerulonephritis, Microscopic Polyangiitis, Chronic Kidney Disease, Granulomatosis with Polyangiitis, and Kidney Transplant. Dr. Geetha is board certified in American Board Of Internal Medicine.
Background: Focal segmental glomerulosclerosis (FSGS) is a disease that causes scarring in parts of the kidneys that filter waste. This can lead to protein loss in the urine, which can worsen kidney function. The kidneys may fail over time, and dialysis or a kidney transplant may be needed. Other treatments for this disease do not always work and often have adverse effects. Better treatments for FSGS are need...
Summary: The primary objective of this study to evaluate efficacy of ravulizumab compared with placebo on proteinuria reduction and change in eGFR in adult participants with IgAN who are at risk of disease progression.


